Samil Pharmaceutical Co. Ltd. logo

Samil Pharmaceutical Co. Ltd. (000520)

Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM
₩
7,770. 00
-100
-1.2706%
₩
178.44B Market Cap
- P/E Ratio
290.91% Div Yield
106,672 Volume
0 Eps
₩ 7,870
Previous Close
Add Transaction
Day Range
7,480 7,850
Year Range
5,500 12,860
Want to track 000520 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Samil Pharmaceutical Co. Ltd. (000520) Statistics

Valuation metrics

Market Cap 178.44B
Enterprise value 348.39B
Trailing P/E (ttm) -4.73
Forward P/E 83.15
PEG ratio 0.08
Price/Sales (ttm) 0.86
Price/Book (mrq) 1.42
Enterprise Value/Revenue 1.68
Enterprise Value/EBITDA -21.27

Overview

Shares outstanding 21.23M
Float 16M
Shares short -
% Held by insiders 0.26%
% Held by institutions 0.01%
Average volume (10 days) 65.26K
Average volume (90 days) 110.19K

Price summary

52-Week low 5,500
52-Week high 12,860
Beta 0.43
50-Day moving average 7,154.38
200-Day moving average 7,626.64

Dividends and splits

Forward annual dividend rate 290.91
Forward annual dividend yield 0.0393%
Trailing annual dividend rate 72.73
Trailing annual dividend yield 0.0098%
5-Year annual dividend yield 0.73%
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 24 Mar 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.18%
Operating margin -0.15%

Operational effectiveness

Return on assets -0.1%
Return on equity -0.28%

Income Statement

Revenue (ttm) 210.25B
Revenue per share (ttm) 9,706.82
Quarterly revenue growth (yoy) -0.08%
Gross profit (ttm) 77.12B
EBITDA -14.74B
Net income to common (ttm) -34.66B
Diluted EPS (ttm) -1,756.33
Quarterly earnings growth (yoy) 0%

Balance Sheet

Total cash (mrq) 6.41B
Total cash per share (mrq) 286.09
Total debt (mrq) 164.02B
Total Debt/Equity (mrq) 1.4
Current ratio (mrq) 0.48%
Book value per share (mrq) 5,874.8

Cash Flow

Cash flow statement 568.16M
Levered free cash flow (LFCF) -6.76B